
Safety and Immunogenicity of a High-Titered Canarypox Vaccine in Combination With rgp120 in a Diverse Population of HIV-1–Uninfected Adults: AIDS Vaccine Evaluation Group Protocol 022A
Author(s) -
Kalpana Gupta,
Michael G. Hudgens,
Lawrence Corey,
M. Juliana McElrath,
Kent J. Weinhold,
David C. Montefiori,
Geoffrey J. Gorse,
Sharon E. Frey,
Michael C. Keefer,
Thomas G. Evans,
Raphael Dolin,
David H. Schwartz,
Clayton Harro,
Barney S. Graham,
Paul Spearman,
Mark J. Mulligan,
Paul Goepfert
Publication year - 2002
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/00042560-200203010-00005
Subject(s) - immunogenicity , medicine , dosing , vaccination , ctl* , population , adverse effect , modified vaccinia ankara , immunology , vaccinia , confidence interval , virology , antibody , biology , immune system , cd8 , recombinant dna , biochemistry , environmental health , gene